Description
The purpose of this Program Announcement (PAR) is to enable clinical validation of strong candidate biomarkers for neurological diseases and conditions. The goal of this PAR is to enable the rigorous validation of biomarker measurements within the clinical population of interest to establish the positive and negative predictive values of the candidate biomarker consistent with FDA guidelines. This PAR assumes that a candidate biomarker has already been identified, detection method technology has already been developed and analytically validated, and the research and/or clinical need and potential context of use has been identified.
• The opportunity is open to various types of applicants, including public and state-controlled institutions of higher education, Native American tribal governments, non-profits, and small businesses.
• The application deadline is June 22, 2026.
• The opportunity is for a cooperative agreement.
• The award ceiling and floor are not specified.